Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fulgent Genetics, Inc. (FLGT)
USD20.31
-0.12 (-0.56%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
4978 Santa Anita Avenue 91780
El Monte, CA, US
El Monte, CA, US
CEO
Ming Hsieh
Website
fulgentgenetics.com
IPO
2016-09-29
CIK 1674930 ISIN US3596641098
Description
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular profiling for cancer identification, Beacon carrier screening for inherited conditions, and specialized rapid whole genome testing for critically ill infants in NICU and PICU units. Other offerings include a newborn genetic analysis panel, a front-line test to sequence ataxia-related variants, and patient-initiated genetic testing via Picture Genetics. They also provide comprehensive whole exome, clinical exome, whole genome, mutation, and repeat expansion testing, alongside research service tests. For COVID-19, the company delivers next-generation sequencing, reverse transcription polymerase chain reaction (RT-PCR), and antigen-based diagnostic solutions for SARS-CoV-2. Beyond genetic and COVID-19 diagnostics, Fulgent Genetics performs advanced laboratory analyses such as flow cytometry for cell analysis and malignancy monitoring, fluorescence in-situ hybridization (FISH) for specific DNA sequence detection, immunohistochemistry (IHC) to visualize cellular antigens, and cytogenetics for assessing chromosomal anomalies, in addition to molecular testing for both hematopoietic and solid tumors. Their clientele is broad, including insurance companies, hospitals, medical institutions, fellow laboratories, government agencies, payors, municipal bodies, major corporations, and direct patients. The company has formed a strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. Founded in 2011 and headquartered in Temple City, California, the company was previously known as Fulgent Diagnostics, Inc. before adopting its current name in August 2016.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD20.31
-0.12 (-0.56%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
488.5K
Beta
0.92
Float Shares
19.20M
Free Float %
64.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.88% | +5.68% | +9.63% | -31.13% | -45.60% | -39.78% | -21.37% | -55.42% | -76.32% | +72.33% | +72.33% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
20.31
Low
15.00
-26.1%
Consensus
25.50
+25.6%
Median
25.50
+25.6%
High
36.00
+77.3%
DCF (Unlevered)
3.73
-81.6%
DCF (Levered)
7.87
-61.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
15.00
-26.1%
|
| Last Quarter | 1 |
15.00
-26.1%
|
| Last Year | 4 |
25.50
+25.6%
|
| All Time | 9 |
36.89
+81.7%
|
Quality scores
Altman Z-Score
3.43
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+13.8% ★ Q1'26: -3.2% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%-39.7% Q1'26: -116.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-55.1% Q1'26: +2.7% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-21.7% Q1'26: -48.7% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-9.0% Q1'26: -17.3% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+1.8% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-0.17× Q1'26: -0.09× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
18.28M
est: 18.43M (-0.9%)
|
18.73M
est: 19.57M (-4.3%)
|
21.36M
est: 21.54M (-0.8%)
|
32.53M
est: 32.65M (-0.4%)
|
421.71M
est: 326.19M (+29.3%)
|
992.58M
est: 933.03M (+6.4%)
|
618.97M
est: 610.81M (+1.3%)
|
289.21M
est: 290.71M (-0.5%)
|
283.47M
est: 281.98M (+0.5%)
|
322.67M
est: 324.55M (-0.6%)
|
352.20M
351.77M – 352.63M
+8.5% YoY
|
401.70M
401.21M – 402.19M
+14.1% YoY
|
434.90M
433.35M – 436.45M
+8.3% YoY
|
| EBITDA |
2.09M
est: 3.89M (-46.4%)
|
-1.75M
est: -7.96M (+78.0%)
|
-2.91M
est: -2.71M (-7.1%)
|
1.68M
est: 6.90M (-75.7%)
|
293.12M
est: 68.90M (+325.4%)
|
686.96M
est: 627.59M (+9.5%)
|
217.70M
est: 472.75M (-54.0%)
|
-147.45M
est: 12.74M (-1,257.5%)
|
-48.99M
est: 12.36M (-496.4%)
|
-45.83M
est: 14.22M (-422.2%)
|
15.43M
15.42M – 15.45M
+8.5% YoY
|
17.60M
17.58M – 17.63M
+14.1% YoY
|
19.06M
18.99M – 19.13M
+8.3% YoY
|
| EBIT |
918.0K
est: 2.98M (-69.1%)
|
-3.48M
est: -11.32M (+69.3%)
|
-5.07M
est: -4.20M (-20.6%)
|
-428.0K
est: 5.27M (-108.1%)
|
290.16M
est: 52.65M (+451.1%)
|
675.95M
est: 610.10M (+10.8%)
|
185.04M
est: 448.80M (-58.8%)
|
-173.60M
est: -5.69M (-2,951.9%)
|
-73.92M
est: -5.52M (-1,239.7%)
|
-69.95M
est: -6.35M (-1,001.5%)
|
-6.89M
-6.90M – -6.88M
-8.5% YoY
|
-7.86M
-7.87M – -7.85M
-14.1% YoY
|
-8.51M
-8.54M – -8.48M
-8.3% YoY
|
| Net Income |
-5.35M
est: 9.90M (-154.0%)
|
-2.51M
est: -8.53M (+70.6%)
|
-5.61M
est: -5.00M (-12.0%)
|
-411.0K
est: 3.45M (-111.9%)
|
214.31M
est: 189.21M (+13.3%)
|
507.36M
est: 460.60M (+10.2%)
|
143.40M
est: 336.61M (-57.4%)
|
-167.83M
est: -168.15M (+0.2%)
|
-42.71M
est: 9.86M (-533.0%)
|
-60.51M
est: 8.31M (-828.5%)
|
-47.70M
-47.78M – -47.63M
-674.3% YoY
|
-35.39M
-35.45M – -35.34M
+25.8% YoY
|
-30.47M
-30.52M – -30.42M
+13.9% YoY
|
| SGA |
7.08M
est: 4.72M (+50.1%)
|
9.44M
est: 5.01M (+88.5%)
|
10.19M
est: 9.25M (+10.2%)
|
12.31M
est: 8.35M (+47.4%)
|
30.17M
est: 83.46M (-63.9%)
|
75.17M
est: 66.03M (+13.8%)
|
149.99M
est: 105.97M (+41.5%)
|
130.47M
est: 99.06M (+31.7%)
|
124.35M
est: 96.09M (+29.4%)
|
160.04M
est: 110.59M (+44.7%)
|
120.02M
119.87M – 120.16M
+8.5% YoY
|
136.88M
136.72M – 137.05M
+14.1% YoY
|
148.20M
147.67M – 148.73M
+8.3% YoY
|
| EPS |
-0.30
est: 0.33 (-191.6%)
|
-0.15
est: 0.00 (-4,600.5%)
|
-0.25
est: -0.10 (-163.2%)
|
-0.02
est: 0.11 (-117.5%)
|
9.44
est: 6.26 (+50.9%)
|
17.13
est: 15.68 (+9.2%)
|
4.76
est: 5.61 (-15.2%)
|
-5.63
est: -5.46 (-3.0%)
|
-1.41
est: 0.33 (-533.3%)
|
-1.97
est: 0.28 (-803.8%)
|
-1.55
-1.55 – -1.55
-653.8% YoY
|
-1.15
-1.15 – -1.15
+25.8% YoY
|
-0.99
-0.99 – -0.99
+13.9% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | Piper Sandler | Neutral | Neutral | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-15 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-108.40M
OE per share TTM
-3.52
Owner's Yield
-22.19%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
17.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
29
Total invested
5.28M
Insider transactions (90d)
3
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 3.53M | 12.00% | — | — | — | — | HC | Delaware | 2023-01-20 | ↗ |
| 2 | 10 | 2.03M | 11.50% | 2.03M | — | 2.03M | — | CO | Delaware | 2016-10-11 | ↗ |
| 3 | Xi Long USA, Inc. | 1.07M | 4.92% | 1.07M | — | 1.07M | — | CO | Delaware | 2020-06-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
29
-154 vs prev Q
New positions
6
Closed positions
156
Increased
10
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 2.96M -13.2K (-0.4%) | 77.82M +10.6M (+15.7%) | 9.63% -0.017 pp | 0.00% +0.000 pp | USD21.97 +19.6% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 1.26M +80.8K (+6.8%) | 33.10M +6.4M (+24.2%) | 4.10% +0.273 pp | 0.00% +0.000 pp | USD42.78 -38.6% | 37 qtrs — |
| 3 | ACADIAN ASSET MANAGEMENT LLC | 1.19M +45.7K (+4.0%) | 31.14M +5.4M (+20.9%) | 3.86% +0.159 pp | 0.05% +0.006 pp | USD19.38 +35.6% | 8 qtrs — |
| 4 | MILLENNIUM MANAGEMENT LLC | 939.4K -529.5K (-36.0%) | 24.68M -8.5M (-25.7%) | 3.06% -1.709 pp | 0.01% -0.004 pp | USD21.53 +22.0% | 24 qtrs — |
| 5 | DIMENSIONAL FUND ADVISORS LP | 889.0K -244.1K (-21.5%) | 23.35M -2.3M (-8.8%) | 2.89% -0.784 pp | 0.00% -0.001 pp | USD36.70 -28.4% | 32 qtrs — |
| 6 | RTW INVESTMENTS, LP | 705.0K +705.0K (+100.0%) | 18.52M +18.5M (+100.0%) | 2.29% +2.293 pp | 0.19% +0.186 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 7 | D. E. SHAW & CO., INC. | 701.3K +133.5K (+23.5%) | 18.42M +5.6M (+43.6%) | 2.28% +0.439 pp | 0.01% +0.003 pp | USD20.56 +27.8% | 16 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 508.2K +6.6K (+1.3%) | 13.35M +2.0M (+17.8%) | 1.65% +0.026 pp | 0.00% +0.000 pp | USD47.88 -45.1% | 26 qtrs — |
| 9 | AMERIPRISE FINANCIAL INC | 499.5K +4.6K (+0.9%) | 13.12M +1.9M (+17.3%) | 1.62% +0.019 pp | 0.00% +0.000 pp | USD25.84 +1.7% | 24 qtrs — |
| 10 | STATE STREET CORP | 493.7K -8.3K (-1.7%) | 12.97M +1.6M (+14.3%) | 1.61% -0.023 pp | 0.00% +0.000 pp | USD49.85 -47.3% | 23 qtrs — |
| 11 | DEUTSCHE BANK AG\ | 439.0K -65.5K (-13.0%) | 11.53M +131.1K (+1.1%) | 1.43% -0.209 pp | 0.00% 0.000 pp | USD22.07 +19.0% | 28 qtrs — |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 402.8K +43.5K (+12.1%) | 10.58M +2.5M (+30.3%) | 1.31% +0.145 pp | 0.00% +0.000 pp | USD33.05 -20.5% | 23 qtrs — |
| 13 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 374.8K +43.3K (+13.1%) | 9.85M +2.4M (+31.4%) | 1.22% +0.144 pp | 0.03% +0.002 pp | USD19.47 +34.9% | 6 qtrs — |
| 14 | GOLDMAN SACHS GROUP INC | 348.5K +164.5K (+89.4%) | 9.16M +5.0M (+120.2%) | 1.13% +0.537 pp | 0.00% +0.001 pp | USD26.33 -0.2% | 24 qtrs — |
| 15 | NUVEEN, LLC | 331.6K +40.8K (+14.0%) | 8.71M +2.1M (+32.5%) | 1.08% +0.135 pp | 0.00% +0.001 pp | USD20.19 +30.1% | 4 qtrs — |
| 16 | MORGAN STANLEY | 315.3K +38.7K (+14.0%) | 8.28M +2.0M (+32.5%) | 1.03% +0.128 pp | 0.00% +0.000 pp | USD28.98 -9.4% | 38 qtrs — |
| 17 | TWO SIGMA INVESTMENTS, LP | 297.4K +139.7K (+88.7%) | 7.81M +4.2M (+119.3%) | 0.97% +0.456 pp | 0.01% +0.006 pp | USD23.75 +10.6% | 8 qtrs — |
| 18 | QUBE RESEARCH & TECHNOLOGIES LTD | 286.5K +201.5K (+236.8%) | 7.53M +5.6M (+291.5%) | 0.93% +0.656 pp | 0.01% +0.006 pp | USD24.07 +9.1% | 4 qtrs — |
| 19 | JPMORGAN CHASE & CO | 250.1K -48.9K (-16.3%) | 6.57M -186.9K (-2.8%) | 0.81% -0.156 pp | 0.00% +0.000 pp | USD23.08 +13.8% | 26 qtrs — |
| 20 | CITADEL ADVISORS LLC | 243.1K -128.4K (-34.6%) | 6.39M -2.0M (-23.9%) | 0.79% -0.414 pp | 0.00% 0.000 pp | USD21.56 +21.8% | 22 qtrs — |
| 21 | POINT72 ASSET MANAGEMENT, L.P. | 237.0K -134.3K (-36.2%) | 6.22M -2.2M (-25.8%) | 0.77% -0.434 pp | 0.01% -0.007 pp | USD20.00 +31.4% | 18 qtrs — |
| 22 | DIAMETRIC CAPITAL, LP | 200.2K -41.5K (-17.2%) | 5.26M -202.5K (-3.7%) | 0.65% -0.133 pp | 1.41% -0.616 pp | USD20.70 +26.9% | 5 qtrs — |
| 23 | TWO SIGMA ADVISERS, LP | 193.5K +107.2K (+124.2%) | 5.08M +3.1M (+160.6%) | 0.63% +0.349 pp | 0.01% +0.006 pp | USD23.96 +9.6% | 7 qtrs — |
| 24 | NORTHERN TRUST CORP | 178.8K -22.0K (-11.0%) | 4.70M +159.1K (+3.5%) | 0.58% -0.070 pp | 0.00% +0.000 pp | USD47.06 -44.2% | 26 qtrs — |
| 25 | BARCLAYS PLC | 172.3K -2.6K (-1.5%) | 4.53M +726.4K (+19.1%) | 0.56% -0.007 pp | 0.00% +0.000 pp | USD24.16 +8.7% | 23 qtrs — |
| 26 | PORTOLAN CAPITAL MANAGEMENT, LLC | 169.6K +169.6K (+100.0%) | 4.46M +4.5M (+100.0%) | 0.55% +0.552 pp | 0.24% +0.239 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 27 | PEAPOD LANE CAPITAL LLC | 165.8K +1.2K (+0.7%) | 4.36M +635.3K (+17.1%) | 0.54% +0.005 pp | 3.71% +0.378 pp | USD18.08 +45.3% | 5 qtrs — |
| 28 | BANK OF AMERICA CORP /DE/ | 152.9K -3.3K (-2.1%) | 4.02M +485.5K (+13.7%) | 0.50% -0.010 pp | 0.00% +0.000 pp | USD23.14 +13.5% | 24 qtrs — |
| 29 | JANE STREET GROUP, LLC | 150.0K +23.0K (+18.1%) | 3.94M +1.1M (+37.3%) | 0.49% +0.076 pp | 0.00% +0.000 pp | USD21.88 +20.1% | 24 qtrs — |
| 30 | TREXQUANT INVESTMENT LP | 140.7K -31.6K (-18.4%) | 3.70M -198.5K (-5.1%) | 0.46% -0.101 pp | 0.03% -0.007 pp | USD19.93 +31.8% | 8 qtrs — |
| 31 | ALLIANZ ASSET MANAGEMENT GMBH | 133.5K +42.6K (+46.9%) | 3.51M +1.5M (+70.7%) | 0.43% +0.139 pp | 0.00% +0.001 pp | USD22.93 +14.6% | 3 qtrs — |
| 32 | TCW GROUP INC | 128.4K +— (+0.0%) | 3.37M +471.2K (+16.2%) | 0.42% +0.001 pp | 0.02% 0.000 pp | USD45.72 -42.5% | 15 qtrs — |
| 33 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 125.2K -4.7K (-3.6%) | 3.29M +353.3K (+12.0%) | 0.41% -0.014 pp | 0.02% +0.002 pp | USD19.88 +32.1% | 3 qtrs — |
| 34 | HRT FINANCIAL LP | 124.2K +17.9K (+16.9%) | 3.26M +861.0K (+35.8%) | 0.40% +0.059 pp | 0.01% +0.002 pp | USD19.31 +36.0% | 6 qtrs — |
| 35 | WELLS FARGO & COMPANY/MN | 120.8K +87.3K (+261.1%) | 3.17M +2.4M (+319.7%) | 0.39% +0.284 pp | 0.00% +0.000 pp | USD24.50 +7.2% | 25 qtrs — |
| 36 | TUDOR INVESTMENT CORP ET AL | 116.0K -55.4K (-32.3%) | 3.05M -827.2K (-21.3%) | 0.38% -0.179 pp | 0.01% -0.001 pp | USD19.11 +37.5% | 6 qtrs — |
| 37 | UBS ASSET MANAGEMENT AMERICAS INC | 100.3K +43.0K (+74.9%) | 2.63M +1.3M (+103.3%) | 0.33% +0.140 pp | 0.00% +0.000 pp | USD26.86 -2.2% | 21 qtrs — |
| 38 | BANK OF NEW YORK MELLON CORP | 84.7K +5.7K (+7.2%) | 2.23M +439.1K (+24.6%) | 0.28% +0.019 pp | 0.00% +0.000 pp | USD46.11 -43.0% | 24 qtrs — |
| 39 | UBS GROUP AG | 83.6K +62.1K (+288.8%) | 2.20M +1.7M (+352.0%) | 0.27% +0.202 pp | 0.00% +0.000 pp | USD24.83 +5.8% | 26 qtrs — |
| 40 | RENAISSANCE TECHNOLOGIES LLC | 82.9K +82.9K (+100.0%) | 2.18M +2.2M (+100.0%) | 0.27% +0.270 pp | 0.00% +0.003 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 41 | RUSSELL INVESTMENTS GROUP, LTD. | 78.0K -21.6K (-21.7%) | 2.06M -179.5K (-8.0%) | 0.25% -0.069 pp | 0.00% 0.000 pp | USD20.04 +31.1% | 26 qtrs — |
| 42 | SEI INVESTMENTS CO | 74.6K +149.0 (+0.2%) | 1.96M +277.0K (+16.5%) | 0.24% +0.001 pp | 0.00% +0.000 pp | USD21.72 +20.9% | 6 qtrs — |
| 43 | HENNION & WALSH ASSET MANAGEMENT, INC. | 66.2K +66.2K (+100.0%) | 1.74M +1.7M (+100.0%) | 0.22% +0.215 pp | 0.06% +0.060 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 44 | INVESCO LTD. | 62.0K -7.2K (-10.4%) | 1.63M +65.0K (+4.2%) | 0.20% -0.023 pp | 0.00% +0.000 pp | USD31.29 -16.0% | 26 qtrs — |
| 45 | SQUAREPOINT OPS LLC | 56.2K +6.9K (+14.0%) | 1.48M +362.5K (+32.5%) | 0.18% +0.023 pp | 0.00% +0.001 pp | USD20.98 +25.2% | 6 qtrs — |
| 46 | AMERICAN CENTURY COMPANIES INC | 54.7K -3.9K (-6.7%) | 1.44M +112.2K (+8.5%) | 0.18% -0.012 pp | 0.00% +0.000 pp | USD41.82 -37.2% | 20 qtrs — |
| 47 | CREATIVE PLANNING | 53.7K +2.4K (+4.8%) | 1.41M +252.5K (+21.8%) | 0.17% +0.008 pp | 0.00% +0.000 pp | USD21.03 +24.9% | 8 qtrs — |
| 48 | HSBC HOLDINGS PLC | 52.1K -25.3K (-32.7%) | 1.37M -368.2K (-21.2%) | 0.17% -0.082 pp | 0.00% 0.000 pp | USD22.48 +16.9% | 10 qtrs — |
| 49 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 51.5K +26.9K (+109.3%) | 1.35M +796.9K (+143.3%) | 0.17% +0.088 pp | 0.00% +0.000 pp | USD22.27 +18.0% | 4 qtrs — |
| 50 | FEDERATED HERMES, INC. | 47.1K +552.0 (+1.2%) | 1.24M +185.3K (+17.6%) | 0.15% +0.002 pp | 0.00% +0.000 pp | USD26.82 -2.1% | 22 qtrs — |
| 51 | QUEST PARTNERS LLC | 39.5K +14.5K (+57.9%) | 1.04M +472.7K (+83.6%) | 0.13% +0.047 pp | 0.06% +0.021 pp | USD22.73 +15.6% | 8 qtrs — |
| 52 | SWISS NATIONAL BANK | 39.2K +1.2K (+3.2%) | 1.03M +171.0K (+19.9%) | 0.13% +0.004 pp | 0.00% +0.000 pp | USD58.48 -55.1% | 21 qtrs — |
| 53 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 38.5K +4.6K (+13.4%) | 1.01M +244.3K (+31.9%) | 0.13% +0.015 pp | 0.02% +0.003 pp | USD20.64 +27.3% | 3 qtrs — |
| 54 | PRELUDE CAPITAL MANAGEMENT, LLC | 37.5K -31.7K (-45.8%) | 985.0K -578.7K (-37.0%) | 0.12% -0.103 pp | 0.07% -0.050 pp | USD17.21 +52.6% | 5 qtrs — |
| 55 | AMUNDI | 35.5K +35.5K (+100.0%) | 933.2K +933.2K (+100.0%) | 0.12% +0.116 pp | 0.00% +0.000 pp | USD26.27 +0.0% | 14 qtrs — |
| 56 | SCHONFELD STRATEGIC ADVISORS LLC | 30.5K +30.5K (+100.0%) | 801.3K +801.3K (+100.0%) | 0.10% +0.099 pp | 0.00% +0.004 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 57 | BNP PARIBAS ARBITRAGE, SNC | 30.3K -110.5K (-78.5%) | 794.9K -2.4M (-75.0%) | 0.10% -0.358 pp | 0.00% -0.001 pp | USD21.60 +21.6% | 23 qtrs — |
| 58 | QUANTINNO CAPITAL MANAGEMENT LP | 29.0K +3.1K (+12.2%) | 760.8K +177.4K (+30.4%) | 0.09% +0.011 pp | 0.00% 0.000 pp | USD19.85 +32.3% | 5 qtrs — |
| 59 | RHUMBLINE ADVISERS | 28.7K -4.3K (-12.9%) | 753.0K +8.8K (+1.2%) | 0.09% -0.014 pp | 0.00% +0.000 pp | USD57.05 -54.0% | 22 qtrs — |
| 60 | CAMPBELL & CO INVESTMENT ADVISER LLC | 27.0K +5.4K (+25.1%) | 709.7K +221.7K (+45.4%) | 0.09% +0.018 pp | 0.03% -0.003 pp | USD21.36 +23.0% | 6 qtrs — |
| 61 | VERITION FUND MANAGEMENT LLC | 26.1K -3.2K (-11.0%) | 685.3K +23.0K (+3.5%) | 0.08% -0.010 pp | 0.00% +0.000 pp | USD16.90 +55.4% | 4 qtrs — |
| 62 | VIRGINIA RETIREMENT SYSTEMS ET AL | 25.6K -2.5K (-8.9%) | 672.9K +37.5K (+5.9%) | 0.08% -0.008 pp | 0.00% 0.000 pp | USD17.11 +53.5% | 4 qtrs — |
| 63 | ALPS ADVISORS INC | 25.4K +10.8K (+74.6%) | 666.9K +338.3K (+103.0%) | 0.08% +0.035 pp | 0.00% +0.002 pp | USD22.64 +16.0% | 7 qtrs — |
| 64 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 23.9K -456.0 (-1.9%) | 627.4K +77.3K (+14.1%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD20.04 +31.1% | 7 qtrs — |
| 65 | STRS OHIO | 22.9K +22.6K (+7,533.3%) | 601.6K +594.8K (+8,772.9%) | 0.07% +0.074 pp | 0.00% +0.002 pp | USD26.70 -1.6% | 23 qtrs — |
| 66 | PRICE T ROWE ASSOCIATES INC /MD/ | 22.4K +1.5K (+7.3%) | 589.0K +116.0K (+24.5%) | 0.07% +0.005 pp | 0.00% +0.000 pp | USD38.09 -31.0% | 20 qtrs — |
| 67 | XTX TOPCO LTD | 22.2K +5.5K (+33.1%) | 583.1K +206.3K (+54.7%) | 0.07% +0.018 pp | 0.02% -0.004 pp | USD19.31 +36.0% | 4 qtrs — |
| 68 | LEGAL & GENERAL GROUP PLC | 21.0K -69.0 (-0.3%) | 550.5K +75.3K (+15.9%) | 0.07% +0.000 pp | 0.00% +0.000 pp | USD43.44 -39.5% | 23 qtrs — |
| 69 | JUMP FINANCIAL, LLC | 20.7K -19.7K (-48.7%) | 543.8K -368.2K (-40.4%) | 0.07% -0.064 pp | 0.01% -0.004 pp | USD17.33 +51.6% | 8 qtrs — |
| 70 | GSA CAPITAL PARTNERS LLP | 20.3K -61.2K (-75.1%) | 533.0K -1.3M (-71.1%) | 0.07% -0.198 pp | 0.05% -0.108 pp | USD17.21 +52.6% | 7 qtrs — |
| 71 | COUNTERPOINT MUTUAL FUNDS LLC | 19.3K +19.3K (+100.0%) | 505.7K +505.7K (+100.0%) | 0.06% +0.063 pp | 0.04% +0.038 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 72 | PANAGORA ASSET MANAGEMENT INC | 19.0K +— (+0.0%) | 498.8K +69.7K (+16.2%) | 0.06% +0.000 pp | 0.00% +0.000 pp | USD21.73 +20.9% | 6 qtrs — |
| 73 | ALMITAS CAPITAL LLC | 18.5K -3.0K (-14.0%) | 485.4K +14.0 (+0.0%) | 0.06% -0.010 pp | 0.11% -0.004 pp | USD17.93 +46.5% | 5 qtrs — |
| 74 | ALLIANCEBERNSTEIN L.P. | 18.5K -4.8K (-20.6%) | 484.9K -40.7K (-7.8%) | 0.06% -0.015 pp | 0.00% +0.000 pp | USD52.12 -49.6% | 23 qtrs — |
| 75 | SG AMERICAS SECURITIES, LLC | 18.3K -825.0 (-4.3%) | 482.0K +49.0K (+11.3%) | 0.06% -0.003 pp | 0.00% -0.001 pp | USD22.60 +16.2% | 21 qtrs — |
| 76 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18.2K -255.0 (-1.4%) | 479.4K +61.2K (+14.6%) | 0.06% -0.001 pp | 0.00% +0.000 pp | USD44.85 -41.4% | 23 qtrs — |
| 77 | AQUATIC CAPITAL MANAGEMENT LLC | 18.2K -24.5K (-57.4%) | 479.1K -487.6K (-50.4%) | 0.06% -0.079 pp | 0.01% -0.004 pp | USD19.51 +34.6% | 10 qtrs — |
| 78 | ENGINEERS GATE MANAGER LP | 17.0K +3.3K (+24.1%) | 446.4K +136.9K (+44.2%) | 0.06% +0.011 pp | 0.01% +0.002 pp | USD20.60 +27.5% | 8 qtrs — |
| 79 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 14.0K +14.0K (+100.0%) | 367.1K +367.1K (+100.0%) | 0.05% +0.045 pp | 0.00% +0.003 pp | USD26.27 +0.0% | 17 qtrs — |
| 80 | FRANKLIN RESOURCES INC | 13.9K +3.0K (+27.1%) | 364.3K +117.7K (+47.7%) | 0.05% +0.010 pp | 0.00% +0.000 pp | USD22.63 +16.1% | 6 qtrs — |
| 81 | ALGERT GLOBAL LLC | 13.7K +13.7K (+100.0%) | 360.0K +360.0K (+100.0%) | 0.04% +0.045 pp | 0.01% +0.006 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 82 | METLIFE INVESTMENT MANAGEMENT, LLC | 12.6K +— (+0.0%) | 330.5K +46.2K (+16.2%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD55.48 -52.6% | 22 qtrs — |
| 83 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 12.3K +12.3K (+100.0%) | 323.6K +323.6K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.001 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 84 | MAGNETAR FINANCIAL LLC | 12.2K +12.2K (+100.0%) | 320.7K +320.7K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.003 pp | USD26.27 +0.0% | 7 qtrs — |
| 85 | MACKENZIE FINANCIAL CORP | 12.0K -129.0 (-1.1%) | 317.9K +43.2K (+15.7%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD20.15 +30.4% | 3 qtrs — |
| 86 | HEADLANDS TECHNOLOGIES LLC | 12.0K +2.6K (+26.9%) | 316.4K +101.9K (+47.5%) | 0.04% +0.008 pp | 0.03% +0.009 pp | USD20.66 +27.2% | 11 qtrs — |
| 87 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 10.9K +2.0K (+23.1%) | 285.8K +86.0K (+43.0%) | 0.04% +0.007 pp | 0.00% +0.000 pp | USD44.82 -41.4% | 21 qtrs — |
| 88 | BOOTHBAY FUND MANAGEMENT, LLC | 10.6K -8.8K (-45.3%) | 278.1K -159.0K (-36.4%) | 0.03% -0.028 pp | 0.00% -0.002 pp | USD22.60 +16.2% | 2 qtrs — |
| 89 | PRIME CAPITAL INVESTMENT ADVISORS, LLC | 10.2K +— (+0.0%) | 267.6K +37.4K (+16.2%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD36.89 -28.8% | 11 qtrs — |
| 90 | OXFORD ASSET MANAGEMENT LLP | 9.7K +9.7K (+100.0%) | 254.1K +254.1K (+100.0%) | 0.03% +0.032 pp | 0.10% +0.103 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 91 | R SQUARED LTD | 9.5K -1.6K (-14.1%) | 249.7K -354.0 (-0.1%) | 0.03% -0.005 pp | 0.12% +0.009 pp | USD22.60 +16.2% | 2 qtrs — |
| 92 | INTECH INVESTMENT MANAGEMENT LLC | 9.3K -1.1K (-10.2%) | 243.3K +10.2K (+4.4%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD19.41 +35.3% | 6 qtrs — |
| 93 | FOX RUN MANAGEMENT, L.L.C. | 9.0K +9.0K (+100.0%) | 236.2K +236.2K (+100.0%) | 0.03% +0.029 pp | 0.04% +0.037 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 94 | UNISON ADVISORS LLC | 8.8K +8.8K (+100.0%) | 230.0K +230.0K (+100.0%) | 0.03% +0.029 pp | 0.02% +0.020 pp | USD26.27 +0.0% | 1 qtrs NEW |
| 95 | ADVISORS ASSET MANAGEMENT, INC. | 8.5K +8.1K (+2,205.7%) | 222.9K +214.6K (+2,580.1%) | 0.03% +0.026 pp | 0.00% +0.004 pp | USD26.53 -1.0% | 11 qtrs — |
| 96 | LOS ANGELES CAPITAL MANAGEMENT LLC | 8.3K +8.3K (+100.0%) | 187.6K +187.6K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.001 pp | USD26.27 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
3
Shares acquired
—
Shares disposed
8.8K
Cash buys
—
Cash sales
—
Net activity
-8,753
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,361 | 16.31 | 71.1K | 370,952 | D | ↗ |
| 2026-04-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,747 | 16.31 | 44.8K | 365,800 | D | ↗ |
| 2026-04-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,645 | 16.31 | 26.8K | 993,007 | D | ↗ |
| 2026-03-09 | Hsieh Ming | Director / Officer / 10% Owner | J-Other | D | Forward sale contract (obligation to sell) | 750,000 | 0.00 | — | 0 | I | ↗ |
| 2026-03-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 1,079 | 15.33 | 16.5K | 383,460 | D | ↗ |
| 2026-03-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,133 | 15.33 | 17.4K | 376,894 | D | ↗ |
| 2026-03-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 17,566 | 15.33 | 269.3K | 900,634 | D | ↗ |
| 2026-03-01 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,018 | 15.33 | 15.6K | 1,001,062 | D | ↗ |
| 2026-02-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 1,140 | 24.76 | 28.2K | 384,539 | D | ↗ |
| 2026-02-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,168 | 24.76 | 28.9K | 378,027 | D | ↗ |
| 2026-02-26 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,949 | 24.76 | 73.0K | 918,200 | D | ↗ |
| 2026-02-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 897 | 24.76 | 22.2K | 1,002,080 | D | ↗ |
| 2026-02-24 | Xie Jian | Officer | A-Award | A | Common Stock | 5,862 | 0.00 | — | 337,245 | D | ↗ |
| 2026-02-24 | Kim Paul | Officer | F-InKind | D | Common Stock | 8,456 | 23.09 | 195.2K | 363,108 | D | ↗ |
| 2026-02-24 | Hsieh Ming | Director / Officer / 10% Owner | A-Award | A | Common Stock | 69,294 | 0.00 | — | 921,149 | D | ↗ |
| 2026-02-24 | Gao Hanlin | Officer | A-Award | A | Common Stock | 22,806 | 0.00 | — | 991,615 | D | ↗ |
| 2026-02-23 | Xie Jian | Officer | F-InKind | D | Common Stock | 655 | 23.01 | 15.1K | 331,383 | D | ↗ |
| 2026-02-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 661 | 23.01 | 15.2K | 327,485 | D | ↗ |
| 2026-02-23 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,167 | 23.01 | 49.9K | 797,054 | D | ↗ |
| 2026-02-23 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 403 | 23.01 | 9.3K | 951,156 | D | ↗ |
| 2026-01-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,711 | 27.53 | 129.7K | 332,038 | D | ↗ |
| 2026-01-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 3,004 | 27.53 | 82.7K | 328,146 | D | ↗ |
| 2026-01-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,331 | 27.53 | 36.6K | 951,559 | D | ↗ |
| 2025-12-02 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,140 | 28.33 | 32.3K | 336,749 | D | ↗ |
| 2025-12-02 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,075 | 28.33 | 30.5K | 952,890 | D | ↗ |
| 2025-12-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,131 | 28.52 | 32.3K | 331,150 | D | ↗ |
| 2025-11-28 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,198 | 29.57 | 35.4K | 337,889 | D | ↗ |
| 2025-11-28 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 943 | 29.57 | 27.9K | 953,965 | D | ↗ |
| 2025-11-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,166 | 30.15 | 35.2K | 332,281 | D | ↗ |
| 2025-11-26 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,944 | 30.15 | 88.8K | 799,221 | D | ↗ |
| 2025-11-24 | Xie Jian | Officer | S-Sale | D | Common Stock | 681 | 30.47 | 20.8K | 339,087 | D | ↗ |
| 2025-11-24 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 535 | 30.47 | 16.3K | 954,908 | D | ↗ |
| 2025-11-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 671 | 30.00 | 20.1K | 333,447 | D | ↗ |
| 2025-11-23 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,116 | 30.00 | 63.5K | 802,165 | D | ↗ |
| 2025-11-19 | Xie Jian | Officer | S-Sale | D | Common Stock | 10,000 | 29.10 | 291.0K | 349,768 | D | ↗ |
| 2025-10-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,353 | 23.74 | 103.3K | 359,768 | D | ↗ |
| 2025-10-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,743 | 23.74 | 65.1K | 334,118 | D | ↗ |
| 2025-10-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,642 | 23.74 | 39.0K | 955,443 | D | ↗ |
| 2025-09-03 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,128 | 22.03 | 24.8K | 364,121 | D | ↗ |
| 2025-09-03 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,063 | 22.03 | 23.4K | 957,085 | D | ↗ |
| 2025-09-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,131 | 22.17 | 25.1K | 336,861 | D | ↗ |
| 2025-08-27 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,199 | 21.48 | 25.8K | 365,249 | D | ↗ |
| 2025-08-27 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 943 | 21.48 | 20.3K | 958,148 | D | ↗ |
| 2025-08-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,166 | 21.47 | 25.0K | 337,992 | D | ↗ |
| 2025-08-26 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,944 | 21.47 | 63.2K | 804,281 | D | ↗ |
| 2025-08-25 | Xie Jian | Officer | S-Sale | D | Common Stock | 696 | 21.50 | 15.0K | 366,448 | D | ↗ |
| 2025-08-25 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 548 | 21.50 | 11.8K | 959,091 | D | ↗ |
| 2025-08-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 670 | 21.77 | 14.6K | 339,158 | D | ↗ |
| 2025-08-23 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,115 | 21.77 | 46.0K | 807,225 | D | ↗ |
| 2025-08-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,339 | 18.53 | 24.8K | 809,340 | D | ↗ |
| 2025-07-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,352 | 18.37 | 79.9K | 367,144 | D | ↗ |
| 2025-07-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,743 | 18.37 | 50.4K | 339,828 | D | ↗ |
| 2025-07-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,642 | 18.37 | 30.2K | 959,639 | D | ↗ |
| 2025-06-09 | Hsieh Ming | Director / Officer / 10% Owner | J-Other | D | Forward sale contract (obligation to sell) | 800,000 | 0.00 | — | 0 | I | ↗ |
| 2025-06-02 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,135 | 20.29 | 23.0K | 371,496 | D | ↗ |
| 2025-06-02 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 754 | 20.29 | 15.3K | 961,281 | D | ↗ |
| 2025-06-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,131 | 20.72 | 23.4K | 342,571 | D | ↗ |
| 2025-05-27 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,183 | 20.52 | 24.3K | 372,631 | D | ↗ |
| 2025-05-27 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 656 | 20.52 | 13.5K | 962,035 | D | ↗ |
| 2025-05-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,166 | 20.31 | 23.7K | 343,702 | D | ↗ |
| 2025-05-26 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,944 | 20.31 | 59.8K | 810,679 | D | ↗ |
| 2025-05-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 671 | 20.31 | 13.6K | 344,868 | D | ↗ |
| 2025-05-23 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,116 | 20.31 | 43.0K | 813,623 | D | ↗ |
| 2025-05-15 | Nohaile Michael | Director | A-Award | A | Common Stock | 4,491 | 0.00 | — | 19,020 | D | ↗ |
| 2025-05-15 | Marsh Linda | Director | A-Award | A | Common Stock | 8,982 | 0.00 | — | 27,641 | D | ↗ |
| 2025-05-15 | GROVES REGINA E | Director | A-Award | A | Common Stock | 8,982 | 0.00 | — | 16,982 | D | ↗ |
| 2025-05-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,339 | 17.25 | 23.1K | 815,739 | D | ↗ |
| 2025-04-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 79 | 17.35 | 1.4K | 963,074 | D | ↗ |
| 2025-04-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,353 | 18.88 | 82.2K | 374,504 | D | ↗ |
| 2025-04-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,743 | 18.88 | 51.8K | 345,539 | D | ↗ |
| 2025-04-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,157 | 18.88 | 21.8K | 963,153 | D | ↗ |
| 2025-03-05 | Kim Paul | Officer | P-Purchase | A | Common Stock | 100,000 | 15.96 | 1.60M | 348,282 | D | ↗ |
| 2025-03-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 1,481 | 15.45 | 22.9K | 378,857 | D | ↗ |
| 2025-03-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,556 | 15.45 | 24.0K | 248,282 | D | ↗ |
| 2025-03-01 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 985 | 15.45 | 15.2K | 964,310 | D | ↗ |
| 2025-02-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,551 | 16.24 | 73.9K | 380,338 | D | ↗ |
| 2025-02-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 4,662 | 16.24 | 75.7K | 249,838 | D | ↗ |
| 2025-02-26 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 11,773 | 16.24 | 191.2K | 817,078 | D | ↗ |
| 2025-02-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 2,523 | 16.24 | 41.0K | 965,295 | D | ↗ |
| 2025-02-25 | Xie Jian | Officer | A-Award | A | Common Stock | 45,304 | 0.00 | — | 384,889 | D | ↗ |
| 2025-02-25 | Kim Paul | Officer | A-Award | A | Common Stock | 5,346 | 0.00 | — | 209,518 | D | ↗ |
| 2025-02-25 | Hsieh Ming | Director / Officer / 10% Owner | A-Award | A | Common Stock | 98,220 | 0.00 | — | 828,851 | D | ↗ |
| 2025-02-25 | Gao Hanlin | Officer | A-Award | A | Common Stock | 4,571 | 0.00 | — | 925,588 | D | ↗ |
| 2025-02-23 | Xie Jian | Officer | F-InKind | D | Common Stock | 719 | 16.46 | 11.8K | 329,229 | D | ↗ |
| 2025-02-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 733 | 16.46 | 12.1K | 200,788 | D | ↗ |
| 2025-02-23 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,324 | 16.46 | 38.3K | 699,915 | D | ↗ |
| 2025-02-23 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 417 | 16.46 | 6.9K | 917,633 | D | ↗ |
| 2025-02-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,472 | 16.64 | 24.5K | 702,239 | D | ↗ |
| 2025-01-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 90 | 17.00 | 1.5K | 918,050 | D | ↗ |
| 2025-01-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,733 | 17.21 | 81.5K | 329,948 | D | ↗ |
| 2025-01-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 3,000 | 17.21 | 51.6K | 201,521 | D | ↗ |
| 2025-01-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,329 | 17.21 | 22.9K | 918,140 | D | ↗ |
| 2024-12-03 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,455 | 19.50 | 28.4K | 334,681 | D | ↗ |
| 2024-12-03 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,373 | 19.50 | 26.8K | 919,469 | D | ↗ |
| 2024-12-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,553 | 18.30 | 28.4K | 204,521 | D | ↗ |
| 2024-11-25 | Xie Jian | Officer | S-Sale | D | Common Stock | 689 | 18.26 | 12.6K | 336,136 | D | ↗ |
| 2024-11-25 | Kim Paul | Officer | F-InKind | D | Common Stock | 669 | 17.87 | 12.0K | 206,074 | D | ↗ |
| 2024-11-25 | Hsieh Ming | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,227 | 18.26 | 40.7K | 703,711 | D | ↗ |
| 2024-11-25 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 497 | 18.26 | 9.1K | 920,842 | D | ↗ |
| 2024-11-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,337 | 21.61 | 28.9K | 705,938 | D | ↗ |
| 2024-10-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 79 | 20.27 | 1.6K | 921,339 | D | ↗ |
| 2024-10-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,345 | 19.42 | 84.4K | 336,825 | D | ↗ |
| 2024-10-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,738 | 19.42 | 53.2K | 206,743 | D | ↗ |
| 2024-10-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,639 | 19.42 | 31.8K | 921,418 | D | ↗ |
| 2024-09-03 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,594 | 21.96 | 35.0K | 341,170 | — | ↗ |
| 2024-09-03 | Kim Paul | Officer | S-Sale | D | Common Stock | 1,674 | 21.96 | 36.8K | 209,481 | — | ↗ |
| 2024-09-03 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,503 | 21.96 | 33.0K | 923,057 | — | ↗ |
| 2024-08-27 | Xie Jian | Officer | S-Sale | D | Common Stock | 715 | 22.83 | 16.3K | 342,764 | — | ↗ |
| 2024-08-27 | Kim Paul | Officer | S-Sale | D | Common Stock | 733 | 22.83 | 16.7K | 211,155 | — | ↗ |
| 2024-08-27 | Hsieh Ming | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,313 | 22.83 | 52.8K | 707,275 | — | ↗ |
| 2024-08-27 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 563 | 22.83 | 12.9K | 924,560 | — | ↗ |
| 2024-08-03 | Xie Jian | Officer | F-InKind | D | Common Stock | 6,719 | 25.06 | 168.4K | 343,479 | — | ↗ |
| 2024-08-03 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,412 | 25.06 | 35.4K | 211,888 | — | ↗ |
| 2024-08-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,337 | 23.57 | 31.5K | 709,588 | — | ↗ |
| 2024-07-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 111 | 23.95 | 2.7K | 925,123 | — | ↗ |
| 2024-07-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,345 | 23.66 | 102.8K | 350,198 | — | ↗ |
| 2024-07-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,738 | 23.66 | 64.8K | 213,300 | — | ↗ |
| 2024-07-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,154 | 23.66 | 27.3K | 925,234 | — | ↗ |
| 2024-06-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 404 | 20.65 | 8.3K | 354,543 | — | ↗ |
| 2024-06-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,129 | 20.65 | 23.3K | 216,462 | — | ↗ |
| 2024-06-01 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 268 | 20.65 | 5.5K | 926,388 | — | ↗ |
| 2024-05-23 | Xie Jian | Officer | F-InKind | D | Common Stock | 653 | 21.14 | 13.8K | 356,022 | — | ↗ |
| 2024-05-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 669 | 21.14 | 14.1K | 217,591 | — | ↗ |
| 2024-05-23 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 362 | 21.14 | 7.7K | 927,370 | — | ↗ |
| 2024-05-16 | Nohaile Michael | Director | A-Award | A | Common Stock | 8,000 | 0.00 | — | 14,529 | — | ↗ |
| 2024-05-16 | Marsh Linda | Director | A-Award | A | Common Stock | 8,000 | 0.00 | — | 18,659 | — | ↗ |
| 2024-05-16 | GROVES REGINA E | Director | A-Award | A | Common Stock | 4,000 | 0.00 | — | 8,000 | — | ↗ |
| 2024-05-03 | Xie Jian | Officer | F-InKind | D | Common Stock | 6,719 | 21.50 | 144.5K | 356,675 | — | ↗ |
| 2024-05-03 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,412 | 21.50 | 30.4K | 218,260 | — | ↗ |
| 2024-05-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,337 | 20.70 | 27.7K | 713,036 | — | ↗ |
| 2024-04-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 79 | 20.35 | 1.6K | 927,732 | — | ↗ |
| 2024-04-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,344 | 20.10 | 87.3K | 363,394 | — | ↗ |
| 2024-04-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,738 | 20.10 | 55.0K | 219,672 | — | ↗ |
| 2024-04-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,154 | 20.10 | 23.2K | 927,811 | — | ↗ |
| 2024-03-08 | Hsieh Ming | Director / Officer / 10% Owner | J-Other | A | Forward sale contract (obligation to sell) | 1,000,000 | 0.00 | — | 1,000,000 | — | ↗ |
| 2024-03-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 1,075 | 23.24 | 25.0K | 368,142 | — | ↗ |
| 2024-03-01 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,129 | 23.24 | 26.2K | 222,834 | — | ↗ |
| 2024-03-01 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 704 | 23.24 | 16.4K | 929,233 | — | ↗ |
| 2024-02-26 | Xie Jian | Officer | A-Award | A | Common Stock | 25,350 | 0.00 | — | 369,217 | — | ↗ |
| 2024-02-26 | Kim Paul | Officer | A-Award | A | Common Stock | 3,927 | 0.00 | — | 198,747 | — | ↗ |
| 2024-02-26 | Hsieh Ming | Director / Officer / 10% Owner | A-Award | A | Common Stock | 20,679 | 0.00 | — | 666,471 | — | ↗ |
| 2024-02-26 | Gao Hanlin | Officer | A-Award | A | Common Stock | 3,927 | 0.00 | — | 906,777 | — | ↗ |
| 2024-02-25 | Xie Jian | Officer | F-InKind | D | Common Stock | 8,031 | 16.29 | 130.8K | 339,585 | D | ↗ |
| 2024-02-23 | Xie Jian | Officer | F-InKind | D | Common Stock | 2,612 | 24.06 | 62.8K | 339,110 | — | ↗ |
| 2024-02-23 | Kim Paul | Officer | F-InKind | D | Common Stock | 2,670 | 24.06 | 64.2K | 194,820 | — | ↗ |
| 2024-02-23 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 8,667 | 24.06 | 208.5K | 632,702 | — | ↗ |
| 2024-02-23 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,617 | 24.06 | 38.9K | 902,850 | — | ↗ |
| 2024-02-03 | Xie Jian | Officer | F-InKind | D | Common Stock | 6,719 | 24.65 | 165.6K | 351,722 | — | ↗ |
| 2024-02-03 | Kim Paul | Officer | F-InKind | D | Common Stock | 982 | 24.65 | 24.2K | 197,490 | — | ↗ |
| 2024-02-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,094 | 24.99 | 27.3K | 641,369 | — | ↗ |
| 2024-01-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 90 | 25.00 | 2.3K | 904,467 | — | ↗ |
| 2024-01-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,683 | 25.60 | 119.9K | 358,441 | — | ↗ |
| 2024-01-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,988 | 25.60 | 50.9K | 198,472 | — | ↗ |
| 2024-01-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 1,325 | 25.60 | 33.9K | 904,557 | — | ↗ |
| 2023-12-31 | Xie Jian | Officer | — | I | Common Stock | 0 | 0.00 | — | 220,816 | — | ↗ |
| 2023-12-11 | Xie Jian | Officer | S-Sale | D | Common Stock | 10,000 | 26.32 | 263.2K | 375,124 | — | ↗ |
| 2023-12-04 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,779 | 27.57 | 49.1K | 385,124 | — | ↗ |
| 2023-12-04 | Kim Paul | Officer | S-Sale | D | Common Stock | 1,437 | 27.57 | 39.6K | 200,460 | — | ↗ |
| 2023-12-04 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,437 | 27.57 | 39.6K | 905,882 | — | ↗ |
| 2023-11-16 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,617 | 27.25 | 44.1K | 386,903 | — | ↗ |
| 2023-11-16 | Kim Paul | Officer | S-Sale | D | Common Stock | 1,307 | 27.25 | 35.6K | 201,897 | — | ↗ |
| 2023-11-03 | Xie Jian | Officer | F-InKind | D | Common Stock | 7,669 | 26.94 | 206.6K | 388,520 | — | ↗ |
| 2023-11-03 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,240 | 26.94 | 33.4K | 203,204 | — | ↗ |
| 2023-11-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 1,309 | 23.75 | 31.1K | 642,463 | — | ↗ |
| 2023-10-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 109 | 23.64 | 2.6K | 907,319 | — | ↗ |
| 2023-10-26 | Xie Jian | Officer | F-InKind | D | Common Stock | 19,833 | 24.03 | 476.5K | 396,189 | — | ↗ |
| 2023-10-26 | Kim Paul | Officer | F-InKind | D | Common Stock | 9,617 | 24.03 | 231.0K | 204,444 | — | ↗ |
| 2023-10-26 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 5,504 | 24.03 | 132.2K | 907,428 | — | ↗ |
| 2023-09-07 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,492 | 31.41 | 46.9K | 416,022 | — | ↗ |
| 2023-09-07 | Kim Paul | Officer | S-Sale | D | Common Stock | 1,492 | 31.41 | 46.9K | 214,061 | — | ↗ |
| 2023-09-07 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,041 | 31.41 | 32.7K | 912,932 | — | ↗ |
| 2023-08-28 | Kim Paul | Officer | S-Sale | D | Common Stock | 10,299 | 33.62 | 346.3K | 215,553 | — | ↗ |
| 2023-08-21 | Hsieh Ming | Director / Officer / 10% Owner | J-Other | A | Forward sale contract (obligation to sell) | 750,000 | 0.00 | — | 750,000 | — | ↗ |
| 2023-08-17 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,307 | 33.88 | 44.3K | 417,514 | — | ↗ |
| 2023-08-17 | Kim Paul | Officer | S-Sale | D | Common Stock | 491 | 33.88 | 16.6K | 227,159 | — | ↗ |
| 2023-08-17 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 342 | 33.88 | 11.6K | 913,973 | — | ↗ |
| 2023-08-03 | Xie Jian | Officer | F-InKind | D | Common Stock | 6,198 | 40.08 | 248.4K | 418,821 | — | ↗ |
| 2023-08-03 | Kim Paul | Officer | F-InKind | D | Common Stock | 1,240 | 40.08 | 49.7K | 227,650 | — | ↗ |
| 2023-08-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 775 | 38.83 | 30.1K | 425,019 | — | ↗ |
| 2023-08-01 | Hsieh Ming | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,783 | 38.83 | 185.7K | 643,772 | — | ↗ |
| 2023-07-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 76 | 38.63 | 2.9K | 914,315 | — | ↗ |
| 2023-06-02 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,433 | 40.30 | 57.7K | 425,794 | — | ↗ |
| 2023-06-02 | Kim Paul | Officer | S-Sale | D | Common Stock | 1,403 | 40.30 | 56.5K | 228,890 | — | ↗ |
| 2023-06-02 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 1,000 | 40.30 | 40.3K | 914,391 | — | ↗ |
| 2023-05-18 | Nohaile Michael | Director | A-Award | A | Common Stock | 2,529 | 0.00 | — | 6,529 | — | ↗ |
| 2023-05-18 | Marsh Linda | Director | A-Award | A | Common Stock | 5,059 | 0.00 | — | 10,659 | — | ↗ |
| 2023-05-18 | GROVES REGINA E | Director | A-Award | A | Stock Option (Right to Buy) | 6,759 | 35.58 | 240.5K | 6,759 | — | ↗ |
| 2023-05-17 | Xie Jian | Officer | S-Sale | D | Common Stock | 1,320 | 35.46 | 46.8K | 427,227 | — | ↗ |
| 2023-05-17 | Kim Paul | Officer | S-Sale | D | Common Stock | 345 | 35.46 | 12.2K | 230,293 | — | ↗ |
| 2023-05-17 | Gao Hanlin | Officer | S-Sale | D | Common Stock | 345 | 35.46 | 12.2K | 915,391 | — | ↗ |
| 2023-05-03 | Xie Jian | Officer | F-InKind | D | Common Stock | 6,198 | 29.33 | 181.8K | 428,547 | — | ↗ |
| 2023-05-03 | Kim Paul | Officer | F-InKind | D | Common Stock | 865 | 29.33 | 25.4K | 231,559 | — | ↗ |
| 2023-05-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 775 | 29.90 | 23.2K | 434,745 | — | ↗ |
| 2023-04-30 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 76 | 29.57 | 2.2K | 915,736 | — | ↗ |
| 2023-03-01 | Xie Jian | Officer | F-InKind | D | Common Stock | 4,045 | 31.85 | 128.8K | 435,520 | — | ↗ |
| 2023-03-01 | KIM PAUL | Officer | F-InKind | D | Common Stock | 433 | 31.85 | 13.8K | 236,229 | — | ↗ |
| 2023-03-01 | Gao Hanlin | Officer | F-InKind | D | Common Stock | 3,804 | 31.85 | 121.2K | 915,812 | — | ↗ |
| 2023-02-27 | Xie Jian | Officer | F-InKind | D | Common Stock | 433 | 32.67 | 14.1K | 439,565 | — | ↗ |
| 2023-02-23 | Xie Jian | Officer | A-Award | A | Common Stock | 2,142 | 0.00 | — | 426,166 | — | ↗ |
| 2023-02-23 | KIM PAUL | Officer | F-InKind | D | Common Stock | 741 | 31.65 | 23.5K | 236,662 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-53.3K
Shares Outstanding
29.75M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Ming Hsieh Chief Executive Officer | 1.00M | — | 4.00M | — | 1.21M | — | 6.21M | 64.44% | ↗ |
| 2 | 2025 | Jian Xie President and Chief Operating Officer | 615.0K | — | 1.85M | — | 334.0K | 13.6K | 2.81M | 65.71% | ↗ |
| 3 | 2025 | Paul Kim Chief Financial Officer | 600.0K | — | 1.80M | — | 325.9K | 47.5K | 2.77M | 64.90% | ↗ |
| 4 | 2025 | Hanlin Gao Chief Scientific Officer and Laboratory Director | 513.0K | — | 1.54M | — | 278.6K | 21.6K | 2.35M | 65.43% | ↗ |
| 5 | 2024 | Ming Hsieh Chief Executive Officer | 1.00M | — | 4.00M | — | 1.13M | — | 6.13M | 65.27% | ↗ |
| 6 | 2024 | Jian Xie President and Chief Operating Officer | 615.0K | — | 1.54M | — | 208.1K | 15.2K | 2.38M | 64.72% | ↗ |
| 7 | 2024 | Paul Kim Chief Financial Officer | 600.0K | — | 1.50M | — | 203.0K | 50.6K | 2.35M | 63.73% | ↗ |
| 8 | 2024 | Hanlin Gao Chief Scientific Officer and Laboratory Director | 513.0K | — | 1.28M | — | 173.6K | 12.9K | 1.98M | 64.71% | ↗ |
| 9 | 2023 | Ming Hsieh Chief Executive Officer | 1.00M | — | 3.00M | — | 1.31M | — | 5.31M | 56.51% | ↗ |
| 10 | 2023 | Jian Xie President and Chief Operating Officer | 615.0K | — | 922.5K | — | 241.5K | 12.2K | 1.79M | 51.50% | ↗ |
| 11 | 2023 | Paul Kim Chief Financial Officer | 600.0K | — | 900.0K | — | 235.7K | 44.0K | 1.78M | 50.57% | ↗ |
| 12 | 2023 | Hanlin Gao Chief Scientific Officer and Laboratory Director | 513.0K | — | 769.5K | — | 201.5K | 6.2K | 1.49M | 51.64% | ↗ |
| 13 | 2022 | Ming Hsieh Chief Executive Officer | 947.9K | 713.6K | 3.57M | — | — | — | 5.23M | 68.26% | ↗ |
| 14 | 2022 | Paul Kim Chief Financial Officer | 579.2K | 128.4K | 3.12M | — | — | 50.0K | 3.87M | 80.44% | ↗ |
| 15 | 2022 | Jian Xie President and Chief Operating Officer | 611.9K | 131.7K | 3.12M | — | — | 12.2K | 3.87M | 80.48% | ↗ |
| 16 | 2022 | Hanlin Gao Chief Scientific Officer and Laboratory Director | 510.3K | 109.8K | 3.12M | — | — | 10.5K | 3.75M | 83.16% | ↗ |
| 17 | 2021 | Ming Hsieh Chief Executive Officer | 664.3K | 5.00M | — | — | — | — | 5.66M | 0.00% | ↗ |
| 18 | 2021 | Ming Hsieh President and Chief Executive Officer | 664.3K | 5.00M | — | — | — | — | 5.66M | 0.00% | ↗ |
| 19 | 2021 | Hanlin Gao Chief Scientific Officer and Laboratory Director | 427.3K | 200.0K | 269.6K | — | — | 3.3K | 900.1K | 29.95% | ↗ |
| 20 | 2021 | Han Lin Gao Chief Scientific Officer and Laboratory Director | 427.3K | 200.0K | 269.6K | — | — | 3.3K | 900.1K | 29.95% | ↗ |
| 21 | 2021 | Jian Xie Chief Operating Officer | 495.9K | 200.0K | — | — | — | 8.7K | 704.6K | 0.00% | ↗ |
| 22 | 2021 | Jian Xie President and Chief Operating Officer | 495.9K | 200.0K | — | — | — | 8.7K | 704.6K | 0.00% | ↗ |
| 23 | 2021 | Paul Kim Chief Financial Officer | 424.9K | 200.0K | — | — | — | 45.1K | 670.0K | 0.00% | ↗ |
| 24 | 2020 | Jian Xie Chief Operating Officer | 210.0K | 8.0K | 5.68M | — | — | 6.5K | 5.91M | 96.20% | ↗ |
| 25 | 2020 | Paul Kim Chief Financial Officer | 210.0K | 8.0K | 1.14M | — | — | 35.7K | 1.39M | 81.76% | ↗ |
| 26 | 2020 | Ming Hsieh President and Chief Executive Officer | 240.0K | 8.0K | — | — | — | — | 248.0K | 0.00% | ↗ |
| 27 | 2020 | Han Lin Gao Chief Scientific Officer and Laboratory Director | 210.0K | 8.0K | — | — | — | 5.5K | 223.5K | 0.00% | ↗ |
| 28 | 2019 | Jian Xie Chief Operating Officer | 205.4K | — | 657.4K | — | — | 6.2K | 869.0K | 75.65% | ↗ |
| 29 | 2019 | Paul Kim Chief Financial Officer | 210.0K | — | 581.8K | — | — | 31.7K | 823.5K | 70.65% | ↗ |
| 30 | 2019 | Han Lin Gao Chief Scientific Officer and Laboratory Director | 210.0K | — | 113.4K | — | — | 6.3K | 329.7K | 34.39% | ↗ |
| 31 | 2019 | Ming Hsieh President and Chief Executive Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 32 | 2018 | Paul Kim Chief Financial Officer | 210.0K | — | — | — | — | 31.1K | 241.1K | 0.00% | ↗ |
| 33 | 2018 | Ming Hsieh President and Chief Executive Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 34 | 2018 | Han Lin Gao Chief Scientific Officer and Laboratory Director | 210.0K | — | — | — | — | 6.3K | 216.3K | 0.00% | ↗ |
| 35 | 2017 | Paul Kim Chief Financial Officer | 210.0K | — | — | — | — | 32.9K | 242.9K | 0.00% | ↗ |
| 36 | 2017 | Ming Hsieh President and Chief Executive Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 37 | 2017 | Han Lin Gao Chief Scientific Officer and Laboratory Director | 210.0K | — | — | — | — | 3.2K | 213.2K | 0.00% | ↗ |
| 38 | 2016 | Paul Kim Chief Financial Officer | 161.8K | — | 2.39M | — | — | 21.0K | 2.58M | 92.91% | ↗ |
| 39 | 2016 | Han Lin Gao Chief Scientific Officer and Lab Director | 194.0K | — | — | — | — | 4.0K | 198.0K | 0.00% | ↗ |
| 40 | 2016 | Han Lin Gao Chief Scientific Officer and Laboratory Director | 194.0K | — | — | — | — | 4.0K | 198.0K | 0.00% | ↗ |
| 41 | 2016 | Ming Hsieh President and Chief Executive Officer | 67.4K | — | — | — | — | — | 67.4K | 0.00% | ↗ |
| 42 | 2015 | Han Lin Gao Chief Scientific Officer and Lab Director | 180.0K | 10.0K | 5.02M | — | — | 5.4K | 5.21M | 96.25% | ↗ |
| 43 | 2015 | Paul Kim Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 44 | 2015 | Ming Hsieh President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ming Hsieh | Chairman & Chief Executive Officer | 2M | male |
| Paul Kim | Chief Financial Officer | 973.4K | male |
| Jian Xie | Chief Operating Officer & President | 962.7K | male |
| Hanlin Gao FACMG | Chief Scientific Officer & Laboratory Director | 813.2K | — |
| Jakub Sram | Vice President of Business Development & Sales | — | male |
| Natalie Prescott | General Counsel & Chief Privacy Officer | — | female |
| Brandon Perthuis | Chief Commercial Officer | — | male |
| Ray Yin | President & Chief Scientific Officer of Fulgent Pharma | — | — |
| Doreen Ng | Vice President of Operations & Compliance | — | female |
| Elias Nyankojo | Chief Information Security Officer | — | male |
| Ellen Tsui | Vice President of Human Resources | — | female |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FLGT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
